Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  Teufel, Andreas ^a   Gerken, Michael ^a   Hartl, Janine ^a   Itzel, Timo ^a   Fichtner Feigl, Stefan ^a   Stroszczynski, Christian ^a   Schlitt, Hans Jürgen ^a   Hofstädter, Ferdinand ^a   Klinkhammer Schalke, Monika ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Adjuvant therapy; Colon cancer; Colorectal cancer; T4 stage; UICC II

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; AGE; CANCER GRADING; COLONIC NEOPLASMS; DISEASE FREE SURVIVAL; PATHOLOGY;

ADENOCARCINOMA; AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FLUOROURACIL; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84930677703     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1404-9     Document Type: Article

References (15)

1. Ferlay J, Parkin DM, Steliarova-Fouscher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765-81.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
3. Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg. 2009;22:191-7.
4. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383:1490-502.
5. Bokemeyer B, Bock H, Huppe D, Düffelmeyer M, Rambow A, Tacke W, et al. Screening colonoscopy for colorectal cancer prevention: results from a German online registry on 269,000 cases. Eur J Gastroenterol Hepatol. 2009;21:650-5.
6. Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343-51.
7. de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18:2938-47.
8. Wils J. Adjuvant treatment of colon cancer: past, present and future. J Chemother. 2007;19:115-22.
9. Schmoll HJ, van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol. 2012;23:2479-516.
10. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. J Clin Oncol. 1999;17:1356-63.
11. Mamounas E, Wieand S, Wolmark N, Bear HD, Atkins JN, Song K, et al. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04). J Clin Oncol. 1999;17:1349-55.
12. Quasar Collaborative Group, Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet. 2007;370:2020-9.
13. Figueredo A, Germond C, Maroun J, Browman G, Walker-Dilks C, Wong S, et al. Adjuvant therapy for stage II colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group. Cancer Prev Control. 1997;1:379-92.
14. Benson 3rd AB, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22:3408-19.
15. Curvo-Semedo L, Lambregts DM, Maas M, Thywissen T, Mehsen RT, Lammering G, et al. Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy-conventional MR volumetry versus diffusion-weighted MR imaging. Radiology. 2011;260:734-43.